Daily Dose - May 9th, 2025
Daily Dose |
View online
May 9, 2025
Takeda to invest $30B in US operations over the next five years
CEO Christophe Weber said that the investment is not a new strategy and reflects the position of the U.S. as the world’s leading market for biopharma innovation.
Read More
Lonza affirms 2025 outlook following strong Q1 across CDMO and CHI segments
New contracts, demand trends and updated timelines shape Q1 qualitative update.
Read More
NecstGen, Astraveus to test benchtop platform for scalable CAR-T production
Partnership to evaluate closed-system microfluidics in GMP cell therapy setting.
Read More